Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. O'Carroll (Dublin, Ireland), A. Mcgowan (Dublin, Ireland), C. Gough (Dublin, Ireland), W. Shah (Dublin, Ireland), C. Burke (Dublin, Ireland). Antibiotics and the microbiome in asthmatic patients. 2346

Member's Comments

No comment yet.

Related content which might interest you: The study of airway microbiome and mycobiome of COPD and AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 The airway microbiota and exacerbations of COPD Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020 Year: 2020 Anti-IL-5 therapy and the airway microbiome in asthma. Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Antibiotics in exacerbations of asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The intestinal microflora in healthy and wheezing infants Source: Eur Respir J 2005; 26: Suppl. 49, 693s Year: 2005 Gut microbiome in COPD Source: International Congress 2016 – Microbiome in health and in disease Year: 2016 Bacterial dysbiosis in pediatric lung diseases such as asthma and CF Source: Virtual Congress 2020 – Bugs secret's: the way the microbiome changes our future Year: 2020 Antibiotics use for asthma exacerbation in Japanese geriatric patients Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 The impact of smoking on airway microbiome and mycobiome of COPD/AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Bacterial infection in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002 The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 A study of the airway mycobiome in COPD patients and controls Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019 Gut microbiota in wheezing preschool children and the development of childhood asthma Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors Year: 2019 Inhaled corticosteroids, bacterial load and the lung microbiome in COPD Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019 Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Upper airways diseases in allergic and nonallergic asthma patients and nonasthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 589s Year: 2004 Spectrum of sputum microflora during infectious exacerbation of bronchial asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Targeting microbes and dysbiosis in severe asthma Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players? Year: 2019 The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013